Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.48 |
| ▸ | LMNA | P02545 | 3/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 4/20 | 0.47 |
| ▸ | USP2 | O75604 | 4/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.39 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.39 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.39 |
| ▸ | PGR | P06401 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6131221 | 0.92 | TDP1 (0.48) | TDP1ALDH1A1LMNAHSD17B10MAPT | |
| SCHEMBL10020242 | 0.90 | TDP1 (0.47) | TDP1ALDH1A1LMNAHSD17B10MAPT | |
| SCHEMBL23818606 | 0.90 | TDP1 (0.47) | TDP1ALDH1A1LMNAHSD17B10MAPT | |
| SCHEMBL13176451 | 0.90 | TDP1 (0.47) | TDP1ALDH1A1LMNAHSD17B10MAPT | |
| SCHEMBL8074473 | 0.89 | ALDH1A1 (0.58) | TDP1ALDH1A1LMNAHSD17B10MAPT | |
| SCHEMBL15249360 | 0.88 | TDP1 (0.45) | TDP1ALDH1A1LMNAHSD17B10MAPT | |
| SCHEMBL10799810 | 0.88 | MEN1 (0.47) | TDP1ALDH1A1LMNAMAPTUSP2 | |
| SCHEMBL821544 | 0.88 | TDP1 (0.45) | TDP1ALDH1A1LMNAHSD17B10MAPT | |
| SCHEMBL22985141 | 0.88 | LMNA (0.50) | TDP1ALDH1A1LMNAHSD17B10MAPT | |
| SCHEMBL19484390 | 0.88 | TDP1 (0.45) | TDP1ALDH1A1LMNAHSD17B10MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 219 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114878542-B | Be used for simultaneously detecting intracellular Cu of mitochondria+And Cu2+Surface-enhanced Raman spectrum probe of (2), preparation and application thereof | 华东师范大学 | 2025-02-11 | — | — | CN | claimed |
| US-20220184165-A1 | Novel Compounds and Pharmaceutical Preparations | DICOT AB (SE) | 2022-06-16 | — | — | US | claimed |
| CN-108314685-B | Preparation method of 2-amino-6-chloro-9- (4-acetoxyl-3-acetoxymethyl butyl) purine | 上药康丽（常州）药业有限公司 | 2020-08-25 | — | — | CN | claimed |
| CN-108484605-B | Preparation method of 2-amino-6-chloro-9- (4-acetoxyl-3-acetoxymethyl butyl) purine | 上药康丽（常州）药业有限公司 | 2020-08-21 | — | — | CN | claimed |
| CN-108484605-A | A kind of chloro- 9- of 2- amino -6-（4- acetoxy-3s-acetyl-o-methyl butyl）The preparation method of purine | 上药康丽（常州）药业有限公司 | 2018-09-04 | — | — | CN | claimed |
| CN-108314685-A | A kind of chloro- 9- of 2- amino -6-（4- acetoxy-3s-acetyl-o-methyl butyl）The preparation method of purine | 上药康丽（常州）药业有限公司 | 2018-07-24 | — | — | CN | claimed |
| EP-2162145-B1 | NOVEL COMPOUNDS AND PHARMACEUTICAL PREPARATIONS FROM NEOBEGUEA SPEC | DICOTYLEDON AB (SE) | 2016-05-04 | — | — | EP | claimed |
| US-20100247593-A1 | NOVEL COMPOUNDS AND PHARMACEUTICAL PREPARATIONS | DICOTYLEDON AB (SE) | 2010-09-30 | — | — | US | claimed |
| US-20100163484-A1 | Compound for denitrifying wastewater | HOOT AEROBIC SYSTEMS, INC. | 2010-07-01 | — | — | US | claimed |
| US-20100068197-A1 | PHARMACEUTICAL COMPOUNDS AS INHIBITORS OF CELL PROLIFERATION AND THE USE THEREOF | MYRIAD PHARMACEUTICALS, INC. (US) | 2010-03-18 | — | — | US | claimed |
| EP-2162145-A2 | NOVEL COMPOUNDS AND PHARMACEUTICAL PREPARATIONS FROM NEOBEGUEA SPEC | Dicotyledon AB (SE) | 2010-03-17 | — | — | EP | claimed |
| US-20090236283-A1 | Method of Denitrifying Wastewater | CORMIER, TROY L. | 2009-09-24 | — | — | US | claimed |
| WO-2009114464-A1 | PROCESS FOR RECOVERY OF POLYHYDROXYALKANOATES FROM BIOMASS | ARCHER-DANIELS-MIDLAND COMPANY (US) | 2009-09-17 | — | — | WO | claimed |
| US-20090233338-A1 | PROCESS FOR RECOVERY OF POLYHYDROXYALKANOATES FROM BIOMASS | ARCHER-DANIELS-MIDLAND COMPANY | 2009-09-17 | — | — | US | claimed |
| WO-2008145996-A2 | NOVEL COMPOUNDS AND PHARMACEUTICAL PREPARATIONS | DICOTYLEDON AB (SE) | 2008-12-04 | — | — | WO | claimed |
| US-20080035538-A1 | Apparatus For And Method Of Denitrifying Wastewater | CORMIER, TROY L. | 2008-02-14 | — | — | US | claimed |
| EP-0036155-A2 | Polymerisable phospholipids, process for their preparation, polymeric phospholipids, process for their preparation as well as the use of the polymeric phospholipids | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 1981-09-23 | — | — | EP | claimed |
| US-20260060261-A1 | ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE THEREOF | Thippareddi Harshavardhan (US) | 2026-03-05 | — | — | US | disclosed |
| US-4046887-A | Glycerides with anti-inflammatory properties | ABBOTT LABORATORIES (US) | 1977-09-06 | — | — | US | disclosed |
| US-3988446-A | Glycerides with anti-inflammatory properties | ABBOTT LABORATORIES (US) | 1976-10-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220184165-A1 | Novel Compounds and Pharmaceutical Preparations | PDE8B, PDE3B, PDE4D | TDP1 1776/4885ALDH1A1 2608/4885LMNA 4654/4885 |
| US-20260060261-A1 | ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE THEREOF | MLYCD, ACADM, MAFG | TDP1 4387/4885ALDH1A1 724/4885LMNA 3681/4885 |
| US-20100163484-A1 | Compound for denitrifying wastewater | DCXR, SQOR, NDUFV2 | TDP1 2252/4885ALDH1A1 1145/4885LMNA 4011/4885 |
| US-20100247593-A1 | NOVEL COMPOUNDS AND PHARMACEUTICAL PREPARATIONS | PDE4B, ACHE, PDE5A | TDP1 1090/4885ALDH1A1 3611/4885LMNA 4608/4885 |
| US-20100068197-A1 | PHARMACEUTICAL COMPOUNDS AS INHIBITORS OF CELL PROLIFERATION AND THE USE THEREOF | MKI67, CCNI, CCNA1 | TDP1 2846/4885ALDH1A1 463/4885LMNA 2800/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.